Compare Stocks → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:CAPCBATS:DJANNASDAQ:GRI Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCAPCCapstone Companies$0.01$0.02$0.01▼$0.08$546K-0.3228,574 shs17,116 shsDJANFT Vest U.S. Equity Deep Buffer ETF - January$36.07+0.0%$35.37$0.00▼$0.00$180.33M0.32N/A67,040 shsGRIGRI Bio0.76-2.1%1.190.75▼115.50$491K-1.79743,292 shs122,100 shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCAPCCapstone Companies+12.73%-27.49%-12.06%+3.33%-75.80%DJANFT Vest U.S. Equity Deep Buffer ETF - January+0.17%-0.11%+1.30%+4.23%+17.59%GRIGRI Bio+3.12%-2.51%-11.82%-71.58%+77,599,900.00%Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCAPCCapstone CompaniesN/AN/AN/AN/AN/AN/AN/AN/ADJANFT Vest U.S. Equity Deep Buffer ETF - JanuaryN/AN/AN/AN/AN/AN/AN/AN/AGRIGRI Bio0.6494 of 5 stars0.04.00.00.03.00.80.6Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCAPCCapstone CompaniesN/AN/AN/AN/ADJANFT Vest U.S. Equity Deep Buffer ETF - January0.00N/AN/AN/AGRIGRI BioN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCAPCCapstone Companies$350K1.56N/AN/A($0.01) per share-1.10DJANFT Vest U.S. Equity Deep Buffer ETF - JanuaryN/AN/AN/AN/AN/AN/AGRIGRI BioN/AN/AN/AN/A38.62 per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCAPCCapstone Companies-$2.66MN/A0.00∞N/A-1,967.36%N/A-134.79%3/29/2024 (Estimated)DJANFT Vest U.S. Equity Deep Buffer ETF - JanuaryN/AN/A18.42∞N/AN/AN/AN/AN/AGRIGRI Bio-$7.02M-81.48N/A∞N/AN/A-595.60%-315.73%3/29/2024 (Estimated)DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCAPCCapstone CompaniesN/AN/AN/AN/AN/ADJANFT Vest U.S. Equity Deep Buffer ETF - JanuaryN/AN/AN/AN/AN/AGRIGRI Bio1.91251.32%N/AN/A N/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCAPCCapstone CompaniesN/A0.110.04DJANFT Vest U.S. Equity Deep Buffer ETF - JanuaryN/AN/AN/AGRIGRI BioN/A2.012.01OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCAPCCapstone CompaniesN/ADJANFT Vest U.S. Equity Deep Buffer ETF - JanuaryN/AGRIGRI Bio33.95%Insider OwnershipCompanyInsider OwnershipCAPCCapstone Companies40.00%DJANFT Vest U.S. Equity Deep Buffer ETF - JanuaryN/AGRIGRI Bio16.82%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCAPCCapstone Companies749.64 million29.79 millionNot OptionableDJANFT Vest U.S. Equity Deep Buffer ETF - JanuaryN/A5.00 millionN/ANot OptionableGRIGRI Bio1646,000537,000Not OptionableCAPC, DJAN, HLCL, GRI, and LSL HeadlinesSourceHeadlineTamil Nadu Newsprint & Papers Share Pricebusiness-standard.com - March 28 at 7:19 PMSteven Ehrlich donates professional archive to Architecture and Design Collection at UCSB’s AD&A Museumarchpaper.com - March 28 at 7:19 PMGRI Bio to Present at the MedInvest Biotech & Pharma Investor Conferenceglobenewswire.com - March 28 at 9:00 AMUCSB Art Museum Collection adds Archive of Modernist Architect Steven Ehrlichnoozhawk.com - March 18 at 9:11 PMProminent Modernist Steven Ehrlich Adds Architectural Archives to UC Santa Barbara Art Museumindependent.com - March 15 at 8:03 PMGRI Bio, Inc.: GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulatorsfinanznachrichten.de - March 14 at 1:50 PMGRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulatorsfinance.yahoo.com - March 14 at 8:50 AMGRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulatorsglobenewswire.com - March 14 at 8:45 AMGRI Bio, Inc.: GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdomfinanznachrichten.de - March 4 at 12:43 PMGRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdomglobenewswire.com - March 4 at 8:30 AMTop 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)benzinga.com - February 23 at 7:50 AMGRI Bio: Entry Into A Material Definitive Agreement, Other Eventscbonds.com - February 5 at 2:06 PMGRI Bio Launches Major Securities Public Offeringmsn.com - February 3 at 2:55 PMGRI Bio prices 5M shares at $1.10 in public offeringmsn.com - February 2 at 12:29 PMGRI Bio Shares Drop After Stock Offering Prices Below Thursday's Closemarketwatch.com - February 2 at 12:29 PMGRI Bio Announces Pricing Of $5.5 Mln Public Offering, Stock Downmarkets.businessinsider.com - February 2 at 12:29 PMWhy Is GRI Bio (GRI) Stock Down 21% Today?investorplace.com - February 2 at 11:07 AMSamsung Galaxy Fit3 tüm ayrıntılarıyla belli oldu: İşte özellikleridonanimhaber.com - January 31 at 12:56 PMGRI Bio, Inc.: GRI Bio Announces Reverse Stock Splitfinanznachrichten.de - January 26 at 7:25 PMGRI Bio's board OKs 1-for-7 reverse stock splitmsn.com - January 26 at 7:25 PMGRI Bio Announces Reverse Stock Splitfinance.yahoo.com - January 26 at 7:25 PMGRI Bio: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listingcbonds.com - January 10 at 3:34 PMGRI Bio, Inc. (GRI) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - January 9 at 1:17 PMGalore Appoints a New Chairman and New Directorbr.advfn.com - January 6 at 3:27 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesHow to Invest in Artificial Intelligence in These Simple WaysMarch 7, 2024 1:08 PMView How to Invest in Artificial Intelligence in These Simple Ways5 Under-the-Radar Artificial Intelligence (AI) Stocks March 4, 2024 9:30 AMView 5 Under-the-Radar Artificial Intelligence (AI) Stocks Your Comprehensive Guide to Investing in Bank StocksMarch 1, 2024 10:41 AMView Your Comprehensive Guide to Investing in Bank StocksThe Ozempic Diet Trend is Lifting These 2 Carnivore StocksMarch 4, 2024 6:28 AMView The Ozempic Diet Trend is Lifting These 2 Carnivore StocksWendy's Walks Back Surge Pricing Talk After Social Media GrillingFebruary 29, 2024 9:30 AMView Wendy's Walks Back Surge Pricing Talk After Social Media GrillingAll Headlines Company DescriptionsCapstone CompaniesOTCMKTS:CAPCCapstone Companies, Inc., through its subsidiaries, engages in the development, marketing, and sale of consumer home light-emitting diode (LED) lighting products for indoor and outdoor applications worldwide. Its lighting products include connected surfacessmart mirrors and standard rectangular wardrobe/fitness mirrors. The company markets its products under the Capstone Lighting brand name, as well as under the Hoover Home LED brand through a network of direct sales force, retailers, and distributors. It sells its products through e-commerce websites. The company was formerly known as CHDT Corporation and changed its name to Capstone Companies, Inc. in June 2012. Capstone Companies, Inc. is headquartered in Deerfield Beach, Florida.FT Vest U.S. Equity Deep Buffer ETF - JanuaryBATS:DJANThe FT Cboe Vest U.S. Equity Deep Buffer ETF - January (DJAN) is an exchange-traded fund that is based on the SPDR S&P 500 ETF Trust index. The fund aims for specific buffered losses and capped gains on SPY ETF over a specific holdings period. The actively-managed fund holds options and collateral. DJAN was launched on Jan 15, 2021 and is managed by First Trust.GRI BioNASDAQ:GRIGRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.